Obesity-hypoventilation in Metabolic Syndrom Patients
Launched by SOS OXYGENE MEDITERRANEE · Apr 6, 2021
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a condition called obesity-hypoventilation syndrome, which can happen in people with metabolic syndrome. The goal is to see how common this condition is among patients who have metabolic syndrome and are also dealing with obesity. If you or someone you know is between the ages of 65 and 74, has a body mass index (BMI) over 30 (which means they are considered obese), and is not currently using treatments like CPAP or non-invasive ventilation, they might be eligible to participate in the study.
Participants in this trial will help researchers better understand how often obesity-hypoventilation syndrome occurs in this group of patients. It’s important to note that individuals with obstructive respiratory disease or untreated heart problems will not be included in the study. If eligible, participants can expect to contribute to valuable research that could improve care for people facing similar health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI\>30 kg/m2
- • no treatment with CPAP nor NIV
- Exclusion Criteria:
- • obstructive respiratory disease
- • non-treated cardiac dysfunction
About Sos Oxygene Mediterranee
SOS Oxygene Mediterranee is a clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapies and interventions. With a focus on respiratory health and related conditions, the organization collaborates with healthcare professionals, research institutions, and regulatory bodies to conduct rigorous clinical trials. By prioritizing patient safety and ethical standards, SOS Oxygene Mediterranee aims to contribute valuable insights to the medical community and enhance the quality of care for individuals affected by respiratory diseases. Their commitment to scientific excellence and patient-centered research drives their mission to foster breakthroughs in medical treatment and improve the lives of patients in the Mediterranean region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bondigoux, , France
Patients applied
Trial Officials
Mathieu Despeaux, MD
Principal Investigator
Clinique du Chateau de Vernhes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials